Fulzos is a prescription medication used to treat hormone-receptor positive advanced breast cancer in postmenopausal women who have not responded to other treatments.
Composition:
Fulzos is a clear, colorless solution containing 250mg of fulvestrant per milliliter.
Mechanism of Action:
Fulvestrant works by:
- Binding to estrogen receptors in the breast and blocking the effects of estrogen on cancer cells
- Reducing the growth and progression of cancer cells
Uses:
Fulzos is used to treat:
- Hormone-receptor positive advanced breast cancer in postmenopausal women who have not responded to other treatments
- Estrogen receptor-positive breast cancer that has progressed on or after prior endocrine therapy
Dosage:
The recommended dosage of Fulzos is:
- 250mg administered as a single intramuscular injection into the buttock area
- Repeat every 14 days for up to 2 years
Side Effects:
Common side effects of Fulzos include:
- Hot flashes
- Musculoskeletal pain
- Fatigue
- Headache
- Nausea and vomiting
- Increased risk of infection
- Increased risk of bleeding
- Low white blood cell count
- Low platelet count
- Arthritis
- Joint pain
Recommendation:
Fulzos is recommended for patients with hormone-receptor positive advanced breast cancer who have not responded to other treatments. Patients should also be advised to monitor their blood counts and liver function regularly during treatment.
Important Note:
Patients should not take Fulzos if they have a history of severe allergic reactions, liver problems, or kidney problems. Patients should also inform their healthcare provider if they have any underlying medical conditions, such as heart problems or lung problems, before taking Fulzos.
Some common brands of fulvestrant include:
- Faslodex (AstraZeneca)
- Fulvestrant (various manufacturers)
Please note that Fulzos is not available in all markets and may be approved for different indications and dosages in different regions.
Reviews
There are no reviews yet.